Arcus Biosciences Inc 
                
                
                    
                        
                    
                
                
                    
                    
                    
                    
                        XNYS: RCUS
                    
                    
                
                
                
                
                    
            
                Arcus Biosciences Inc Live Stock Price Today, Share Analysis and Chart
                    about
                    
                        
            
        Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to...
Read More
            
                20.35
            
            
            0.63
            
                (3.19%)
            
        
        
    
                    
                        
                        6.1M
                    
                    
                
                        XNYS Volume
                        
                            
                                
                High volume today
XNYS 03 Nov, 2025 4:30 PM (EST)
                
                Board Meeting
            
            The next board meeting for Arcus Biosciences Inc is on 06 Nov 2025 for the purpose of Arcus Biosciences Inc Third Quarter Earnings Results for 2025
            See details
         
                
                    
                        Low Financial Strength
                    
                
            
        
                
                    
                        Expensive Valuation
                    
                
            
        
                
                    
                        Technically Bullish
                    
                
            
        
                                        Momentum Trap
                                        These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
                                        View Similar
                                        
                                            
                                                
                                                    
                                                
                                                
                                                    
                                                
                                                
                                                    
                                                
                                            
                                            Embed DVM
                                            
                                                
                                            
                                        
                                    
                                
                            
                        
                    
                Arcus Biosciences Inc Live Price Chart
        
        Switch to TradingView
        
            
            
        
    
Loading Fundamental data..
Loading data..